Suppr超能文献

HCMOGT-1是一种在伴有t(5;17)(q33;p11.2)的青少年粒单核细胞白血病中与PDGFRB形成的新型融合伴侣。

HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).

作者信息

Morerio Cristina, Acquila Maura, Rosanda Cristina, Rapella Annamaria, Dufour Carlo, Locatelli Franco, Maserati Emanuela, Pasquali Francesco, Panarello Claudio

机构信息

Dipartimento di Ematologia ed Oncologia Pediatrica, Istituto di Ricovero e Cura a Carattere Scientifico Istituto G. Gaslini, Genova, Italy.

出版信息

Cancer Res. 2004 Apr 15;64(8):2649-51. doi: 10.1158/0008-5472.can-03-4026.

Abstract

PDGFRB, a transmembrane tyrosine kinase receptor for platelet-derived growth factor, is constitutively activated by gene fusion with different partners in myeloproliferative/myelodysplastic disorders with peculiar clinical characteristics. Six alternative partner genes have been described thus far. In this study, we report the molecular cloning of a novel translocation t(5;17)(q33;p11.2) in a case of juvenile myelomonocytic leukemia. The novel partner gene was identified as HCMOGT-1 using 5'-rapid amplification of cDNA ends; fluorescence in situ hybridization and reverse transcriptase-PCR analyses confirmed that the translocation resulted in PDGFRB/HCMOGT-1 fusion. We show that the breakpoint of PDGFRB occurred at the same site of all previously reported PDGFRB translocations.

摘要

血小板衍生生长因子受体β(PDGFRB)是一种血小板衍生生长因子的跨膜酪氨酸激酶受体,在具有特殊临床特征的骨髓增殖性/骨髓增生异常性疾病中,它通过与不同伙伴的基因融合而持续激活。迄今为止,已描述了六个替代伙伴基因。在本研究中,我们报告了一例青少年骨髓单核细胞白血病中一种新型易位t(5;17)(q33;p11.2)的分子克隆。使用5'-cDNA末端快速扩增法将新型伙伴基因鉴定为HCMOGT-1;荧光原位杂交和逆转录酶-PCR分析证实该易位导致了PDGFRB/HCMOGT-1融合。我们表明,PDGFRB的断点发生在所有先前报道的PDGFRB易位的相同位点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验